35. Which one of the following could result in better outcomes for type
2 diabetics?
1. An increased rate of gluconeogenesis in the liver.
2. Lower production of insulin.
3. An increased A1C percentage.
4. An increa
...
35. Which one of the following could result in better outcomes for type
2 diabetics?
1. An increased rate of gluconeogenesis in the liver.
2. Lower production of insulin.
3. An increased A1C percentage.
4. An increased number of GluT4 transporters in the cell membrane.
36. Emma was prescribed metformin which is used to control blood
glucose levels. One direct effect of metformin is inhibition of the
_________ pathway in the liver.
1. Glycolysis
2. Glycogenesis
3. Gluconeogenesis
4. Option 4
37. Emma has an A1C level of 7.0% in her blood. A1C is a form
of__________________.
1. Hemoglobin
2. Insulin
3. Enzyme
4. Hormone
23. Metformin treatment is able to lower blood glucose levels by _______
gluconeogenesis in the liver cells and _________ Glut4 translocation in the
muscle or fat cells.
1. decreasing, increasing
2. increasing, decreasing
3. maintaining, decreasing
4. increasing, maintaining
48. What is the product of glycogenesis?
1. glycogen
2. glucose
3. glucagon15. Billy is a 26-year-old male currently on his 12th day of a hunger strike to
protest “government stuff.” How can Billy keep going long after his glycogen
supply has been used up? (Note: The brain requires a constant supply of
glucose to function.)
1. He uses fatty acids to create new glucose through gluconeogenesis.
2. He uses glycerol, some amino acids, and other molecules to create new
glucose.
3. All amino acids can be used to create glucose through gluconeogenesis.
24. Insulin is a hormone that is secreted when blood glucose is
_______. This hormone stimulates _______ in the cell.
1. high, glycogenesis
2. high, gluconeogenesis
3. low, glycogenolysis
4. low, glycogenesis
11. Hemoglobin A1c (sometimes referred to simply as A1c) is a molecule
measured for a laboratory test. It is used to confirm the diagnosis of
diabetes and to assess a diabetic patient’s level of disease control. How and
why do advanced glycation end products
(AGEs)
[Show More]